Loading...

Durazo Francisco

TitleDirector
InstitutionUniversity of California Los Angeles
DepartmentHepatology
AddressBOX 957302 200 Medical Plaza Suite 214
Los Angeles CA 90095
Phone(310) 825-5318
vCardDownload vCard
    Other Positions
    TitleMedical Director

    TitleHealth Sciences Associate Clinical Professor

    TitleHealth Sciences Associate Clinical Professor


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yanny B, Saab S, Durazo F, Latt N, Mitry A, Mikhail MM, Hanna RM, Aziz A, Sahota A. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA?
      View in: PubMed
    2. Saab S, Barnard A, Challita Y, Adeniyi A, Aziz A, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients. Exp Clin Transplant. 2018 Aug; 16(4):419-424. PMID: 30060729.
      View in: PubMed
    3. Jacobs JP, Dong TS, Agopian V, Lagishetty V, Sundaram V, Noureddin M, Ayoub W, Durazo F, Benhammou J, Enayati P, Elashoff D, Goodman MT, Pisegna J, Hussain S. Microbiome and Bile Acid Profiles in Duodenal Aspirates from Cirrhotics: The Microbiome, Microbial Markers and Liver Disease Study. Hepatol Res. 2018 Jun 20. PMID: 29923681.
      View in: PubMed
    4. Phan J, Ng V, Sheinbaum A, French S, Choi G, El Kabany M, Durazo F, Saab S, Tong M, Busuttil R, Han SH. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis. J Clin Gastroenterol. 2018 Jun 16. PMID: 29912756.
      View in: PubMed
    5. Lee EW, Saab S, Kaldas F, Fletcher S, Busuttil RW, Durazo F, McWilliams JP, DiNorcia J, Padia SA, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy. Am J Gastroenterol. 2018 Jun 14. PMID: 29899437.
      View in: PubMed
    6. Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. J Clin Transl Hepatol. 2018 Sep 28; 6(3):247-250. PMID: 30271735.
      View in: PubMed
    7. Saab S, Sikavi C, Jimenez M, Viramontes M, Allen R, Challita Y, Mai M, Esmailzadeh N, Grotts J, Choi G, Durazo F, El-Kabany M, Han SH, Moreno E. Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients. J Clin Transl Hepatol. 2017 Dec 28; 5(4):335-342. PMID: 29226100.
      View in: PubMed
    8. Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C. J Clin Transl Hepatol. 2017 Jun 28; 5(2):101-108. PMID: 28660147.
      View in: PubMed
    9. Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El-Kabany MM, Han SB, Saab S. Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. J Clin Transl Hepatol. 2017 Mar 28; 5(1):43-49. PMID: 28507926.
      View in: PubMed
    10. Vidhyarkorn S, Siripongsakun S, Yu J, Sayre J, Agopian VG, Durazo F, Lu DS. Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients. Liver Transpl. 2017 03; 23(3):324-329. PMID: 27875639.
      View in: PubMed
    11. Saab S, A Jimenez M, N Bau S, Choi G, Durazo FA, M El-Kabany M, Han SB, Busuttil RW. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis. J Clin Gastroenterol. 2017 Feb; 51(2):167-173. PMID: 27548734.
      View in: PubMed
    12. Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ. Limited Knowledge of Acetaminophen in Patients with Liver Disease. J Clin Transl Hepatol. 2016 Dec 28; 4(4):281-287. PMID: 28097095.
      View in: PubMed
    13. Lee EW, Kuei A, Saab S, Busuttil RW, Durazo F, Han SH, El-Kabany MM, McWilliams JP, Kee ST. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2016 Jul 07; 22(25):5780-9. PMID: 27433091; PMCID: PMC4932213.
    14. Kuei A, Lee EW, Saab S, Busuttil RW, Durazo F, Han SH, ElKabany M, McWilliams JP, Kee ST. Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012. Dig Dis Sci. 2016 10; 61(10):2838-2846. PMID: 27349987.
      View in: PubMed
    15. Flores YN, Auslander A, Crespi CM, Rodriguez M, Zhang ZF, Durazo F, Salmerón J. Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers. J Dig Dis. 2016 May; 17(5):304-12. PMID: 26991251; PMCID: PMC4956543 [Available on 05/01/17].
    16. Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW. Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. J Clin Transl Hepatol. 2016 Mar 28; 4(1):32-8. PMID: 27047770; PMCID: PMC4807141.
    17. Lu NT, Crespi CM, Liu NM, Vu JQ, Ahmadieh Y, Wu S, Lin S, McClune A, Durazo F, Saab S, Han S, Neiman DC, Beaven S, French SW. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. Phytother Res. 2016 Jan; 30(1):160-8. PMID: 26621580.
      View in: PubMed
    18. Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis. Clin Transplant. 2015 Sep; 29(9):813-9. PMID: 26147216.
      View in: PubMed
    19. Felker ER, Lee-Felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS. Intraductal Cooling via a Nasobiliary Tube During Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries. AJR Am J Roentgenol. 2015 Jun; 204(6):1329-35. PMID: 26001245.
      View in: PubMed
    20. Saab S, Greenberg A, Li E, Bau SN, Durazo F, El-Kabany M, Han S, Busuttil RW. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. Liver Int. 2015 Nov; 35(11):2442-7. PMID: 25913321.
      View in: PubMed
    21. Lee EW, Saab S, Gomes AS, Busuttil R, McWilliams J, Durazo F, Han SH, Goldstein L, Tafti BA, Moriarty J, Loh CT, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results. Clin Transl Gastroenterol. 2014 Oct 02; 5:e61. PMID: 25273155; PMCID: PMC4218931.
    22. Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, Durazo F, Honda H, Gornbein J, Wu V, Farmer DG, Hiatt JR, Busuttil RW. Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg. 2014 Jun; 259(6):1186-94. PMID: 24263317.
      View in: PubMed
    23. Saab S, Manne V, Bau S, Reynolds JA, Allen R, Goldstein L, Durazo F, El-Kabany M, Han S, Busuttil RW. Boceprevir in liver transplant recipients. Liver Int. 2015 Jan; 35(1):192-7. PMID: 24673728.
      View in: PubMed
    24. Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg. 2013 Sep; 258(3):409-21. PMID: 24022434.
      View in: PubMed
    25. Chavalitdhamrong D, Jensen DM, Singh B, Kovacs TO, Han SH, Durazo F, Saab S, Gornbein JA. Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clin Gastroenterol Hepatol. 2012 Mar; 10(3):254-8.e1. PMID: 22155754.
      View in: PubMed
    26. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg. 2011 Jun; 146(6):683-9. PMID: 21690444.
      View in: PubMed
    27. Saab S, Ng V, Landaverde C, Lee SJ, Comulada WS, Arevalo J, Durazo F, Han SH, Younossi Z, Busuttil RW. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transpl. 2011 May; 17(5):567-79. PMID: 21506245.
      View in: PubMed
    28. Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, Hong JC, Farmer D, Busuttil RW. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. Liver Transpl. 2011 May; 17(5):580-90. PMID: 21506246.
      View in: PubMed
    29. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg. 2011 Apr; 212(4):514-20; discussion 520-1. PMID: 21463781.
      View in: PubMed
    30. Han SH, Durazo FA, Saab S, Tong MJ. A proposed, evidence-based approach to the treatment of chronic Hepatitis B. J Clin Gastroenterol. 2011 Mar; 45(3):259-66. PMID: 20856136.
      View in: PubMed
    31. Tabibian JH, Lazo M, Durazo FA, Yeh HC, Tong MJ, Clark JM. Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population? J Gastroenterol Hepatol. 2011 Mar; 26(3):501-9. PMID: 21332546; PMCID: PMC4937792.
    32. Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):709-17. PMID: 20385251.
      View in: PubMed
    33. Tong MJ, Hsu L, Hsien C, Kao JH, Durazo FA, Saab S, Blatt LM. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatol Int. 2010 Apr 07; 4(2):516-22. PMID: 20827410; PMCID: PMC2896649.
    34. Tabibian JH, Asham EH, Han S, Saab S, Tong MJ, Goldstein L, Busuttil RW, Durazo FA. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc. 2010 Mar; 71(3):505-12. PMID: 20189508.
      View in: PubMed
    35. Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ, Hayashi P, Lee WM, Seeff LB. Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol. 2010 Jul; 105(7):1561-6. PMID: 20104221; PMCID: PMC3825455.
    36. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl. 2009 Nov; 15(11):1525-34. PMID: 19877207.
      View in: PubMed
    37. Landaverde C, Ng V, Sato A, Tabibian J, Durazo F, Busuttil R. De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis. Ann Hepatol. 2009 Oct-Dec; 8(4):379-83. PMID: 20009140.
      View in: PubMed
    38. Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):793-9. PMID: 19306949.
      View in: PubMed
    39. Tong MJ, Hsien C, Song JJ, Kao JH, Sun HE, Hsu L, Han SH, Durazo FA, Saab S, Blatt LM. Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Dig Dis Sci. 2009 Jun; 54(6):1337-46. PMID: 19242792.
      View in: PubMed
    40. Tabibian JH, Asham EH, Goldstein L, Han SH, Saab S, Tong MJ, Busuttil RW, Durazo FA. Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc. 2009 Jun; 69(7):1236-43. PMID: 19249040.
      View in: PubMed
    41. Shim M, Durazo F. Multinodular fatty liver after herpes-zoster vaccine: case report and review of the literature. Ann Hepatol. 2008 Oct-Dec; 7(4):382-5. PMID: 19034241.
      View in: PubMed
    42. Saab S, Ibrahim AB, Surti B, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Pretransplant variables associated with quality of life in liver transplant recipients. Liver Int. 2008 Sep; 28(8):1087-94. PMID: 18662279.
      View in: PubMed
    43. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2008 Oct; 23(10):1541-8. PMID: 18422961.
      View in: PubMed
    44. Tabibian JH, Lassman CR, Margolis DJ, Landaverde C, Busuttil RW, Durazo FA. Intraductal oncocytic papillary neoplasm of the liver: case and review of a rare variant. Ann Hepatol. 2008 Apr-Jun; 7(2):168-73. PMID: 18626437.
      View in: PubMed
    45. Saab S, Wiese C, Ibrahim AB, Peralta L, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Employment and quality of life in liver transplant recipients. Liver Transpl. 2007 Sep; 13(9):1330-8. PMID: 17763388.
      View in: PubMed
    46. Yan E, Durazo F, Tong M, Hong K. Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr Rev. 2007 Aug; 65(8 Pt 1):376-84. PMID: 17867371.
      View in: PubMed
    47. Spiegel BM, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan HA, Durazo F, Bacon B, Martin P, Younossi Z, Hwa-Ong S, Kanwal F. Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0. Hepatology. 2007 Jul; 46(1):113-21. PMID: 17596882.
      View in: PubMed
    48. Saab S, Oh MK, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. Liver Transpl. 2007 Jul; 13(7):1032-8. PMID: 17600345.
      View in: PubMed
    49. Cameron AM, Ghobrial RM, Hiatt JR, Carmody IC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han SH, Saab S, Gornbein J, Busuttil RW. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg. 2006 Oct; 244(4):563-71. PMID: 16998365; PMCID: PMC1856558.
    50. Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality. Exp Clin Transplant. 2006 Jun; 4(1):395-9. PMID: 16827633.
      View in: PubMed
    51. Saab S, Niho H, Comulada S, Hiatt J, Durazo F, Han S, Farmer DG, Holt C, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver Int. 2005 Oct; 25(5):940-5. PMID: 16162150.
      View in: PubMed
    52. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, Saab S, Han S, Durazo F, Weaver M, Cao C, Chen T, Lipshutz GS, Holt C, Gordon S, Gornbein J, Amersi F, Ghobrial RM. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005 Jun; 241(6):905-16; discussion 916-8. PMID: 15912040; PMCID: PMC1357170.
    53. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005 May; 41(5):1130-7. PMID: 15841454.
      View in: PubMed
    54. Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J, Farmer DG, Ghobrial RM, Holt C, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl. 2005 Feb; 11(2):218-23. PMID: 15666392.
      View in: PubMed
    55. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl. 2004 Dec; 10(12):1478-86. PMID: 15558585.
      View in: PubMed
    56. Neff GW, Reddy KR, Durazo FA, Meyer D, Marrero R, Kaplowitz N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol. 2004 Dec; 41(6):1062-4. PMID: 15582145.
      View in: PubMed
    57. Saab S, Kalmaz D, Gajjar NA, Hiatt J, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Goldstein LI, Lassman CR, Busuttil RW. Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl. 2004 Jul; 10(7):859-67. PMID: 15237369.
      View in: PubMed
    58. Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H, Goldstein RL, Ghobrial M, Busuttil RW. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol. 2004 May; 99(5):950-2. PMID: 15128366.
      View in: PubMed
    59. Kanwal F, Chen D, Ting L, Gornbein J, Saab S, Durazo F, Yersiz H, Farmer D, Ghobrial RM, Busuttil RW, Han SH. A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl. 2003 Dec; 9(12):1312-9. PMID: 14625832.
      View in: PubMed
    60. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003 Oct; 9(10):1053-61. PMID: 14526400.
      View in: PubMed
    61. Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Busuttil RW. Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant. 2003 Sep; 3(9):1167-72. PMID: 12919097.
      View in: PubMed
    62. Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Chen P, Schwegel K, Goldstein LI, Tong M, Busuttil RW. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003 Jul; 9(7):672-81. PMID: 12827551.
      View in: PubMed
    63. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, Weaver M, Figueroa J, Khan K, Vargas J, Saab S, Han S, Durazo F, Goldstein L, Holt C, Busuttil RW. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003 May; 237(5):666-75; discussion 675-6. PMID: 12724633; PMCID: PMC1514517.
    64. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM, Busuttil RW. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003 May; 9(5):473-6. PMID: 12740789.
      View in: PubMed
    65. Saab S, DeRosa V, Nieto J, Durazo F, Han S, Roth B. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastroenterol. 2003 Apr; 98(4):763-70. PMID: 12738453.
      View in: PubMed
    66. Saab S, Hu R, Ibrahim AB, Goldstein LI, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial RM, Farmer DG, Busuttil RW, Lassman C. Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. Am J Transplant. 2003 Mar; 3(3):328-33. PMID: 12614290.
      View in: PubMed
    67. Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holt C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil RW. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl. 2003 Feb; 9(2):182-7. PMID: 12548512.
      View in: PubMed
    68. Ghobrial RM, Saab S, Lassman C, Lu DS, Raman S, Limanond P, Kunder G, Marks K, Amersi F, Anselmo D, Chen P, Farmer D, Han S, Durazo F, Goldstein LI, Busuttil RW. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl. 2002 Oct; 8(10):901-9. PMID: 12360431.
      View in: PubMed
    Francisco's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _